Note: Descriptions are shown in the official language in which they were submitted.
PA TFNT
` 1 3 3 4 9 3 6 540270-2070 FIELD OF THE INVENTION
This invention relates to homeopathic medicaments
and methods for the treatment of illness and injury in human
beings using such homeopathic medicaments.
More particularly, the invention relates to
homeopathic methods of treatment of conditions including
illnesses, pathogenic diseases, allergies, chemical and
hormonal imbalances, addictive chemical dependencies, and
physical injuries to the human body. The methods of treatment
include oral, topical, auricular and injectable forms of
homeopathic formulations which are magneticall~ treated or
influenced durin~ administeration to a patient throuqh
specific acupuncture points.
BACKGROUND OF THE Il~TVENTION
Homeopathy is an ancient healing art and forms a
vital part of medical therapy. The practice of homeopathy is
widespread, particularly in eastern cultures and many European
countries. ~omeopathic medicine teaches the use of natural
based remedies and, as such, provides an alternative to
traditional allopathic medicine whieh relies heavilv on the
use of petrochemical based pharmaceuticals. There has been a
large increase in intere~t in homeopathic medicine in the
United States in recent years due, in large part, to a growin~
disenchantment with allopathic medications and the
complications and side effects arising from their use.
PATE~T
540270-20,0
1 334936
their optimum health~ul ~evel of operation: that is, their
natural biolo~ical "set pointsn.
Through our modern understanding of genetics each
bodily member and pr~cess is seen as the result of code~
programmed into each individual cell. H~m~opathic medicine
seeks t~ utilize natural substances, particularly herbs, to
naturally and ~entlv induce the body to restore its equilibri-
um, that is, for all function and processes to return to their
set points. Homeopathic medicine l~oks upon illness ar.d
disease as being a state of ~ice~uilihrium from the body's
optionai set points. A fundamental precept of homeopa.hic
medicine is that a small force cr s~imulating agent can
produce disproportionally greater results, if optimally and
effectivelv applied. Thus, proper administra-
tion of a small quantitv of a homeopathic medicine can have a
lar~e effect in restoxing the body to its proper state of
equilibrium.
A further advantane of homeopathic medicaments is
that they are relati~ely inexpensive as compared to
traditional chemical-based pharmaceuticals. Another
fundamental precept in the formulation of homeopathic
pharmaceuticals is that repetitive dilution from an oriainal
concentrate does not diminish efficacy of the formulation.
Thus, large quantities o~ homeopathic pharmaceuticals can be
prepared from a relatively small amount of starting solution.
.. . .. -.,
PAT~NT
1 334936 540270-207C
Further, the starting ingredients themselves are natural and
relatively inexpensive. The formulation of solutions of
homeopathic pharmaceuticals is also a relatively simple
process.
In contrast, the manufacture of traditional chemi-
cal-based pharmaceutica~s generall~ involves a complicated and
costlv chemical manufacturing process. Moreover, because the
effectivene~s of such traditional chemical-based pharmaceuti-
cals reside~ in the pctency of the formulation administered,
dilution of the pharmaceutical to a lower potency results in
reduced effectiveness. Generally, all such chemical-based
pharmaceuticals must be formulated at or near the concen-
tratjon level or potencv at which they will ultimatelv be
administ~red. Thus, in order tc produce large quantities of a
pha~aceutical, proportionztely large manufacturing facilities
are reauired, which onlv further adds to the expensiveness of
the chemical-based pharmaceuticals utilized in classical
allopa'hic medicine.
Another ancient and long accepted healing art is
acupuncture which is believed to have originated in the
Orient. Acupuncture involves the relief of symptoms and the
cure of illness and in~ur~ by the controlled stimulation of
points on the human body which regulate or interact with the
functioning of specific organs or bodilv members to which the
acupuncture points are related.
PATENT
1 33~ 93~ 5402/0-7070
Modern science has tried to determine the mechanism
b~ which acu~uncture works. One proposed explanation is that
stimulation of acupuncture points on the bodv causes the
release of endorphins bv the body. Endorphins are natural
substances re~eased within the ~odv which, among other
functjons, operate to desensitize neurological pathwavs by
which pain is perceived. Bv relieving the pain associated
with symptoms and with illness and in~urv, the body itself is
then able to utilize its natural immune system and the healin~
process to restore equilibrium and a normal healthful condi-
tion. Natural set points are restored and the affliction
therebv eliminated. Pain acts as a warning indicator that
something is wrong in the body. ~y determining the source of
the pain and the acupuncture points on the body to which the
pa n s responsive, the pain cycle can be broken and the
natural healing process induced. Stimulation through acupunc-
ture, which typicallv involves the insertion of small needles
into the acupuncture points on the bodv, causes ~ release of
endorphins which block pain sensed over the reuro~ogical
pathways and enable other natural healing mechanisms in the
body to restore a condition of homeopathic equilibrium to the
body bv killina invasi~e pathogens, restoring chemical or
hor~onal imbalance, or fosterina the mendina of physicallv
injured tissues, muscles and/or bones. Over the many years
that acupuncture has been practiced, specific points on the
PAT~T
1 3 3 4 9 3 6 ~40?70-207C
human body have been ~etermine~ which regulate the functioninq
of all bodily members and processes. Thus, the appropriate
points for stimulation for any given condition are known to
skilled ~ractitioners in the art.
One particular acupuncture treatment system
developed in Japan b~ nr. Yoshio Manaka is based on a
conception of the human body as encompassing two basic
systems, an energetic system and an informational svstem. The
energetic svstem utilizes the greater portion of energy in the
~odv. The i~formational svstem controls the energetic svstem
and responds to both external and internal stimuli.
Acun~ncture is viewed as a therapeutic modalitv ~!hich
interacts with and re~ulates the bodv's informational system.
irfluencing the informational svstem, large changes can be
in~uced with minimal stimu'ation while allowino the body to
function as naturally as possible while its processes are
graduallv restored to their equilibrium set points.
A recent development in methods of medical treatmer.t
has been the discovery of the therapeutic properties of
magnetic and electro-magnetic fields and their use in the
treatment of illnes~ and injury. Modern science has
demonstrated that all ]iving beings exhibit ar electro-
magnetic field a~out them. Homeopathic medicine teaches that
illness and inJury create disturbances to the body's natural
electro-magnetic field~. The administration o therapeutic
1 3 3 4 9 3 6 5~0270-~070
-
fields restores the bodv's natural fields to their equilibrium
lev~ls. The therapeutic effects of the application of pulsed
magnetic fields in the treat.ment of traumatic in~uries to
limbs, muscles, tendor.c, bones and the like, as well as in the
treatment of illness such as art.hritis, is well-known in the
art O r medical science.
The human body's susceptihility to magneti~ fields
is due in lar~e part to the electrol~tic propert.es of manv of
the chemical constituents of the body. All electrolytic
substances are capable of conducting an electric current and
wherever ar. electric current is flowing, a magnetic field is
created. The greater t.he electrolyt-c properties of the
substance, the greater is its conductivitY an2 therefore the
qreater the resulting magnetic field created during current
flow.
~ he body generat.es a ma~netic field of its own due
partlv to th~ presence of iron-carryinq charged particles
flowing in the blood stream. Other electrolvtic substances in
the bodv such as potassium and sodium, in ionic form, are
preSent in substantial amounts and contribute to the bodv's
overall bioelectric/biom2gnetic field. It is well ~nown that
bloo~ cells are readily polarized when placed in a ma~netic
field due to the high iron concentration in the blood. Under
cert.ain conditions, magnetic fields alter the orientation of
blood cells and induce changes in the biological reactions in
. . ....
1 3 3 4 9 3 6 5~027~-~070
which they participat~, therebv modifyin~ the probability of
chemical bond formation.
Human blood is very sliqhtly alkaline with respect
to body cells which are more acidic. Magr~tic fields can be
used to induce reactions which restore the pH of the blQod.
For example, in a condition prompted by over-aciditv
of the blood, that is, one characteri~ed by a low pH, applica-
tion of ma~netic field ener~y emanating from the north pole of
a magnet, which, by convention, is considered to be negatl~e,
and which, homeopathically, is considered to be alkaline,
helps to restore the blood to its normal pH level.
It has also been shown that the blood's leucocyte
count is influenced bv ma~netic fields. The number of
leucocvtes in the blood increases or decreases depending on
prevailing maanetic field conditions.
Therapeutic treatments utilizing magnetic energy
operate to produce two curative effects. Therapeutic magnetic
fields produce a treatment component which in the case of
traumatic physical iniury causes a reduction in swelling, a
reducti~n of edema, a drainin~ of fluid build-up due to
inflammation and a desensitization to pain.
Therapeutic magnetic er.ergy fields also produce a
stimulating component which in the case of traumatic physical
injury dilates blood vessels and increaSes blood circulation,
-- 8
PATENT
'- 1 3 3 4 9 3 6 540270-2070 disperses fluid build-up due to inflammation, and strengthens
and promotes the healin~ of damaqed tissue.
The application of pulsed magnetic energy has been
observed to cause transcutaneous electrical neural stimulation
and contributes to the reduction of chronic pain by causing
the release of natural pain relieving substances at the spinal
ccrd level and by causing the release of endorphins and ACTH
at the pituitary gland level.
As a result of research into the fields of
homeopathic pharmaceutical medicine, acupuncture and
biomagnetic therapv, a new modality of medical treatment has
been developed which combines the features of all three of the
abov~ treatment methods in a noval way. Accordingly, a new
and unique method of medical treatment has been discovered
which is more efficacious than any of the three methods
described above.
OBJECT~; OF THE INVENTIO?~
Accordingly, a primarv ob~ect of the present in-
vention is to disclose a new modality of medical therapy which
utilizes aspects of homeopathic pharmaceutical therapy,
acupuncture therapy and biomagnetic therapy, in combination.
A further ob~ect of the invention is to devise a
full range of modes of administration of magnetically induced
~ATE~T
1 3 3 4 9 3 6 540270-2070
homeopathic remedies, including topical, injectable, auricular
and oral forms.
A further ob~e~t of the invention is to provide
particular homeopathic pharmaceutical formu~.ations for the
treatment of specific illnesses, phvsical injuries and other
chemical and hormonal disequilibrium conditions of the human
body with precisely determined acupuncture sites to which the
homeopathic pharmaceutical remedi~s are to be applied in the
treatment of each specific condition.
A further object of the invention is to pro~ide
appropriate means for inducing the biomagnetic field in the
homeopathic pharmaceutical remedy for each form of adminis-
tration.
SU~A~Y OF THF, LNV~TION
The present invention is directed to a method of
treatment of human illness and injury by administering ~o the
patient homeopathic medicaments through selected acupuncture
points stimulated by a controlled magnetic field. A very
broad spectrum of human illnesses can be effecti~ely treated
by homeopathic medicaments of the instant invention through
selection of the appropriate homeopathic remedy, preparation
of a mixture of th~ homeopathic remedv and a magneticallv
permeall~ component and magnetization of the resultin~ mixture
durina administration to the patient through specific
aCUpUllCtUre fii tes.
-- 10 --
PATENT
1 3 3 4 9 3 6 540~70-2n70
Various embodiments of the invention include
administerin~ therapeutic amounts of the magnetic mixture in
oral, injectable, topical and auricular forms. Further,
depending upon the condition being treated the dosage and
frequencv of administration will vary. In a particularly
preferred embodiment the patient is administered with a
regimen of both oral and injectable dosages.
BRIEP DESCRIPTION OF THE DRAWINGS
Aspects of the present invention are illustrated by
the accompanving drawinas in which:
Figures lA and lB show two preferred embodiments of
oral deli~rerY vehicles for the administration of homeopathic
medicaments;
Figures 2A and 2B show embodiments for the topical
administration of a homeopathic medicament;
Figure 3 shows a preferred embodiment for imparting
a magnetic field to the injecta~le form homeopathic
medicaments; and
DETAILED DÆSCRIPTION OF PREFERRED
EMBODIMENTS OF THE INVENTION
The homeopathic medicaments of the present invention
when administered through specific acupuncture sites have
demonstrated remarkable efficacv in the treatment of a wide
range of afflictions, manv of which have no known cure in the
realm of allopathic medicine. Effective delivery systems for
-- 11 --
PATENT
540270-207
1 334936
these homeopathic formulations have been devised including
topical, injectable, auricular and oral forms.
In accordance with the teaching of the present
invention the homeopathic medicament, administered in whatever
form is selected, must first be carefully mixed with an
effective amount of a magnetically permeable ingredient.
Although numerous compounds are suitable, it has been found
that ferrous gluconate is particularly effective. The
resulting mixture is then prepared for administrati~n to the
patient depending upon the specific deliverv system used.
During administration to the patient, the medicament is
charged or influenced b~ a magnetic field which imparts a
unipolar charge to the medicament as it enters the bodv
through a pre-selected acupuncture point. Such application of
a magnetic charge at or in close proximit~" to the acapuncture
site is believed to stimulate or activate the acupuncture site
thereby enhancing the therapeutic efficacy of the medicament
being administered.
Particularly effective results have been achieved
when applying relatively small levels of magnetic charge in
the range of 1 to 10 gaUcs to the medicament as it is being
administered through the acupuncture point. Such low levels
of magnetic flux can ap~lv be described as homeopathic. It
has further been found that the most effective acupuncture
sites are located in the arms and legs below the elbow and
- 12 -
PATENT
; 1 3 3 4 9 3 6 54027~-2070
knee, respectively. These points are commonly referred to as
the "command points" and are well known to those skilled in
the art.
Having described the invention in its most
fundamental terms, the various forms of administration of
medicament will now be described in detail. Reference is made
to the accompanying figures where appropriate.
One delivery system used is by in~ection. The
formulation dosage and duration of treatment for the
injectible medicaments i5 described in detail in the
formulation examples which follow. Since it has been observed
that injecting homeopathic medicaments demonstrate unexpected
and significantlv enhanced efficacy when a unipolar magnetic
charge is imparted to the medicament during administration or
injection into an acupuncture point, a device has been
developed to enable the administering physician to suitably
charge the medicament. One such device is shown in Figure 3.
This device consists of a housing 10 containing an
electromagnetic coil 12 positioned to impart a controlled
magnetic charge to plate 14. A syringe or hypodermic needle
16 used to inject the homeopathic medicament can be positioned
in housing 10 such that the point of the needle or syrinae is
in close proximity to plate 14 as shown in Figure 3.
Another alternative delivery system used is the
topieal. One particularly preferred topical is illustrated in
~ 1 3 3 4 9 3 6 ~4027~-2070
Eigure ~A. The topical patch 20 is made of a porous material
such as sintered metal capable of absorbing a therapeutic
amount of homeopathic medicament. The patch 20 has an
extended opening therethrough in which is tightly fitted a
metal rod or core 22 which can readily accept and retain a
magnetic charge. Suitable materials include iron and nickel.
The patch 20 can then be impregnated with a therapeutic amount
of desired homeopathic medicamer.t. A unipolar magnetic charge
is then imparted ~o the metallic core 22 of patch 20 which is
then affixed to a suitable acupuncture point.
One method for affixing the topical patch to the
acupuncture point is to hold it in place with adhesive
bandage, surgical tape or the like. For preparations that are
to be affixed tG acupur.cture points on the limbs, such as on
the wrists, arms, ankles or legs, the magnetically influenced
homeopathic medicament can be placed in a band which car, be
comfortably strapped around the member at the desired
location.
In certain alternative embodiments, the homeopathic
pharmaceutical formulation can be magnetized in situ by
placing a permanent magnet or other source of magnetic flux on
top of the portion of the homeopathic mixture to be magnet-
icallv activated.
- 14 -
1 3 3 4 9 3 6 540270-2070
Still another form of a topical for administering
homeopathic medicaments is a pellet or "button" as illustrated
in Figure 2B. The button 30 can be stamped out under pressure
in a process generally known as the sintered metal process.
To fabricate the button, a 50/50 powdered mixture of Ni
(nickel) and Fe (iron) is fed into a press mold. This
composition inhibits corrosion and readily accepts and holds a
magnetic charge. Since the finished pellet or button is
porous it can easily be impregnated like a sponge with a
therapeutic homeopathic tincture. The hutton is then formed
with presure to the desired shape.
A protrusion 32 on the underside of button 30
effectively increases the overall therapeutic effect of the
topi~al by providing direct phvsical stimulation of the
acupuncture point. Although other shapes can certainly be
used, the smooth domed top of button 30 is desirable as beinq
less obtrusive on the surface of the skin. After the button
30 is formed and impregnated with medicament, it is
magnetically charge so that the desired polarity is imparted
to the under surface of the button which is affixed in place
over a pre-selected acupuncture point. One polaritv is on the
upper surface of the button (the domed surface awav from the
skinJ and the other pole is on the lower surface of the button
in contact with the skin.
:,
1 3 3 4 9 3 6 54 0270-~07n
-
Still another form of administering homeopathic
medicaments is orall~ by means of a pill or tablet. Two such
oral tablets are shown in Figures lA and lB.
With reference to Figure lA, this oral device can
aptly be described as a medicinal "lollipop" consisting of a
rod portion 40 and a ball or bulbous portion 42. The rod 40
is made up of a metal such a~ iron capable of holding a
magnetic charge. The ball portion 42 has an inert core such
as molded ~lastic, for example. The rod 40 is coated with a
plastic or vinvl coating 44 extending to the ball portion 42.
The ball portion 42 is coated with a homeopathic composition
made of sugar and Ferrous gluconate mixed to a dilution in the
range of 3x to 4x. It is then impregnated with an alcohol
tincture containing the desired homeopathic medicament.
The entir~ device can be encased in a sanitary
wrapping. To use the "lollipop" the entire device in its
wrapping if desired is first placed in a suitable
electromagnetic field. In this way, all of the metallic
elements of the device are magnetized with the ball portion
being charqed with one polarity and the rod portion with the
opposite polarity. In this manner, the therapeutic portion of
the device havinq a unipolar charge can then be placed under
- 16 -
PATENT
1 3 3 4 9 3 6 540270-2070
the tonaue of the patient in order to contact the acupuncture
points in the mouth.
Alternativly, a pill as shown in Figure lB can be
used. The pill 50 has a core 52 formed of a standard
homeopathic sugar globule made in conventional manner. Dry
Ferrous gluconate powder (USP grade) is triturated with very
fine sugar in a 1-9 proportion in a grinding machine to make a
homeopathic dilution of ~X. A second dilution (designed as
3X) is made in the same 1-9 proportions using the 2X dilutior.
and additional sugar. Succeeding dry dilutions are made in
the same manner to a final dilution of 5~. The 5X dilution of
the Ferrous gluconate and sugar is used to build inner layer
54 which surrounds the core 52. Layer 54 is built up by
tumbling in a coating pan in accordance with known methods for
the manufacttlre of homeopathic remedi~s. Layer 54 is then
covered with a coating 56 which is impermeable to water and
alcohol. Ferrous gluconate is added to coating 56 so that it
will have the same maonetic permeability as layer 54
co~taining ferrous gluconate and sugar. An outer layer 58 is
then built up around coatinq 56 in the same manner as inner
layer 54 was formed. The thickness of outer layer 58 should
be approximately twice that of inner layer 52 for o~timum
result~ and is similarly made of a Ferrous gluconate su~ar
mixture in 5X dilution. The pills are then thorou~hly air
PATENT
540270-207
` 1 334936
dried. The diameter of the finished pill should preferably be
appro~imatelv one centimeter.
The layered pill made according to this procedure
can then be medicated in conventional manner. For example, a
measured weight of the finished, dried pills is placed in a
suitable container and a predetermined amount of the desired
homeopa~hic medicinal tincture is added. The homeopathic
tincture is of a dilution of 30X which has been manufactured
in accordance with traditional homeopa~hic procedure from
herbs or other ra~ materials. The containers with the pills
are ther. rotated ir 2 roller mill for approximately cne hour
to permit the pills to completel~ absorb the alcohol tincture.
The pills are then transferred from the containers to paper
covered trays where thev are air dried until no trace or odor
of the alcohol remains. The pills are then individually
packaged (a single pill to each ccntainer) in a vial-like tube
with a threaded cap or tightly fitting friction lid. The cap
is preferably larger in diameter than the vial so that it
projects to form a rim around the vial at the top. Pre-
cautions should be taken during processina to avoid contamina-
tion or de-activation of the pills.
The medicated pill5 can then be administered to the
patient. A vial containing the pills is placed into a suit-
able magnetic filed so that each pill is maqnetized just prior
to in~estion bv the patient. The pill should be inserted
- 18 -
PATENT
1 3 3 4 9 3 6 540~?0-2070
directlv into the mouth from the vial without handling. The
patient can then suck on the pill to qraduallv dissolve it
until the impermeable coatin~ is reached at which point the
patient should discard the remainder of the pill.
Yet another form of administering the homeopathic
medicaments is by auricular measures. One such device consists
of an earplug containing dosages of the homeopathic medicament
which can be administered through holes in the earplug to the
acupuncture points in the ear. The earplug device can be made
by any number of means with the understanding that it must be
able to unccntrollablY release medicament to predetermined
auricular acupuncture points. This can best be accomplished
by ei~her using rods or small protrusions aligned with the
acupuncture points and capable of releasing medicament. For
best results, the homeopathic medicament is magnetized after
it is depcsited in the earplug device in accordance with the
procedure described above for imparting a magnetic charge to
the topical or oral forms of administration.
The following examples illustrate the embodiments of
various aspects of the invention. The examples are provided
to illustrate the scope of the invention and are not intended
to be limiting. Other applications of aspects of the in-
vention within its broad scope will be apparent to those
skilled in the art.
-- 19 --
PATEI~.'T
1 334936 s40270-2070
FOPr,UI.ATION E:XAMPLES
A. INJECTAE?~LE
Example 1
An injectable dosage form of an herb-based
homeopathic medicament designated FNG-11, for the treatment of
fungus and yeast infections, having a homeopathic potency of
30X was prepared from an original concentrated tincture
menstrum containing extracts of the herbs Tecoma conspicuz and
Melaleuca alternifolia in 99+% alcohol. The orioinal
concentrated tincture was then diluted to 30X potency (ln 30
times the original concentration) with sterile isotonic
saline. Ferrous gluconate, a magneticallv permeable substance
in a homeopathic potency of 4 x (10 ), was added to the
dilute homeopathic solution in order for it to hold a magnetic
charge when passed through a magnetic field. Injectable
dosage portions of O.~cc volumes were set aside as needed
depending upon the number of acupuncture points being used.
The formulations injected were controllabl~ magnetized during
administration through the acupuncture sites as described
above.
Example 2
An injectable dosage form of an herb-based
homeopathic medicament, designated HG-9, for the treatment of
intestinal parasites, particularly Giardia lamblia and
Entamoeba histolytica, was prepared from an original
- 20 -
1 334936 PATENT
540~70-2070
concentrated tincture menstruum containing extracts of the
herbs Osbeckia chinensis, Pulsatilla chinensis, Punica
granatum, Acalpha australis, Cephaelis ipecacuanha, Picrasma
ailanthoides, Asarum sieboldi, Brucea javanica, Magnolia
officinalis, Artemysia apiacea, and Dichroa febrifuga in 99+~
alcohol. The original concentrated tincture was then diluted
to 30X potencv (10 30 times the original concentration) with
sterile isotonic saline. Ferrous gluconate, a magneticall~
permeable substance in a homeopathic potency of 4 X (10 4),
was added to the dilute homeopathic solution in order for it
to hold a magnetic charge when passed through a magnetic
field. Injectable dosage portions of 0.2cc volumes were set
aside as needed. The formulations injected were controllablv
magnetized during administration through the acupuncture sites
as described above.
Example 3
An injectable dosage form of an herb-based
homeopathic medicament designated VR-27, for the treatment of
broad spectrum viral infections, having a homeopathic potency
of 30X was prepared from an original concentrated tincture
menstruum containing an extract of the herb Centella asiatica
minor in 99~ alcohol. The original concentrated tincture was
then diluted to 30X potency (10 30 times the original
concentration) with sterile isotonic saline. Ferrous
gluconate, a magnetically permeable substance in a homeopathic
potency of 4 x (10 4), was added to the dilute homeopathic
1 3 3 4 9 3 6 540270-2070
-
solution in ~rder for it to hold a maon~ic charge when passed
through a magnetic field. Injectable do~age portions of Q.2cc
volumes were set aside as needed. The formulations injected
were control~ably magne~L~d during ad~inistxation throu~h the
acupuncture site$ as descrihed above.
E~ample 4
An iniectable dosage form of an herb-based
homeopathic medicament designated ~PN-7, for the treatment Oc
traumatic iniury to muscles, tendons, ligaments, and for the
treatment Oc sprains, was prepared from an original
concentrated tincture menstruum containing extracts of the
herbs Radix pseudoginseng, Dryobalanops aromatica, Gynura
segetum, and Moschus moschiferous in 99+~ alcohol. The
original concentrated tincture was then diluted to 30X potency
(10 30 times the original concentration) with sterile isotonic
saline. Ferrous gluconate, a magnetically permeable substance
in a homeopathic potency of 4 x (10 4), was added to the
di~ute homeopathic solution in order for it to hold a maqnetic
charge when passed through a magnetic field. Injectable
dosage portions of 0.2cc volumes were set aside as needed.
The formulations injected were controllably magnetized during
administration through the acupuncture sites as described
abo~e.
Example 5
PATE~'T
1 3 3 4 9 3 6 540270-~070
Ar. injectable dosage form of an herb-based
homeopathic medicament, designated TYR-l n, for the treatment
of hypothyroidism, was prepared from an original concentrated
tincture menstruum containing ar extract of the herb Organ
protomorphogim in 99+% alcohol. The original concentrated
tincture was then diluted to 30X potencv (10 30 times ~he
original concentration! with sterile isotonic saline. Ferrous
gluconate, a magnetically permeable substance in a homeopathic
potencv of 4 x (10 4), was added to the dilute homeopathic
soluti~n in order for it to hold a magn~tic charge when passed
thr~ugh a magnetic field. Iniectable dosa~e portions of 0.2cc
volumes were set aside as needed. The formulations injected
were controllablv magnetized during administration through the
acupuncture sites as described above.
Example 6
An injectable dosage form of an herb-based
h~meopathic medicament, designated HRM-4, for the treatment of
premenstrual,syndrome, menopause, and reproductive hor,monal
imbalance, was prepared from an original concentrated tincture
menstruum containing an e~tract of the herb Angelica sinensis
in 99+~ alcohol. The original concentrated tincture was then
diluted to 30X potency~(10 30 times the original
concentration) with sterile isotonic sa~ine. Ferrous
gluconate, a magnetically permeable substance
PATENT
1 3 3 4 9 3 6 540270-2070
in a homeopathic potency of 4 x 10 4), was added to the dilute
homeopathic solution in order for it to hold a magnetic charge
when passed through a magnetic field. Injectable dosage
portions of 0.2cc volumes were set aside as needed. The
formulations iniected were contro11ably magnetized during
administration through the acupuncture sites as described
above.
Example 7
An inJectahle dosage form of a homeopathic
med~cament, designated HYT-12, for the treatment of hydro-
thyroidism, was prepared from an original concentrated
tincture menstruum containing a solution of aqueous iodine in
99+% alcohol. The origina1 concentrated tincture was diluted
to 30X potencv (10 30 times the oriqinal concentration) with
sterile isotonic saline. Ferrous gluconate, a magneticallv
permeahle substance in a homeopathic potency of 4 x (10 4),
was added to the dilutç homeopa~hic solution in order for it
to hold a magnetic charge when passed through a magnetic
field. Injectable dosage portions of O.~cc volumes were set
aside as needed. The formulation~ injected were controllablv
magnetized during administration through the acupuncture sites
as described above.
Example 8
- 24 -
PATENT
1 334936 540270-2070
An injectable dosage form of an herb-based
homeopathic medicament for the treatment of hypertension,
designated RLX-22, wa~ prepared from an original tincture
menstruum containing extracts of the herbs Rock Rose,
Clematis, Impatiens, Cherry Plum, and Star of Bethlehem in
99+~ alcohol. The original concentrated tincture was then
diluted to 30X potenc~! ~10 30 times the original concen-
tration) with sterile isotonic saline. Ferrous gluconate, a
magnetically permeable substance in a homeopathic potency of 4
x ~10 4), was added to the dilute homeopathic so~ution in
order for it to hold a magnetic char~e when passed through a
ma~netic field. Iniectabl~ dosage ~ortions of 0.2cc volumes
were set aside as needed. The formulations iniected were
controllably magnetized during administration through ~he
acupuncture sites as described above.
Example 9
An in~ectable dosage form of an herb-based
homeopathic medicament, designated IMM-2, for restoring and
strengthenina the body's natural immune svstem, having a
homeopathic potencv of 30X was prepared from an oriainal
concentrated tincture menstruum containing extracts of the
herbs Astragalus membranaceous, ~'ux vomica, Panix ginseng,
Germanium and extract of Thymus gland in 99+~ alcohol. The
original concentrated tincture was then diluted to 30X potency
PATE~T
1 3 3 4 9 3 6 5402~0-~07n
(10 30 times the original concentration) with sterile isotonic
saline. Ferrous gluconate, a magnetically permeable substance
in a hc~eopathic potency of 4 x (10 4J, was added to the
dilute homeopathic solution in order for it to hold a magnetic
charge when passed through a ma~netic field. Injectable
dosage portions of 0.2cc volumes were set aside as needed.
The formulations iniected were controllably magnetized during
administration through the acupuncture sites as described
above.
Example 10
An in~ectable dosaoe form of a homeopathic
medicament for the treatment of hypoglvcemia, designated
HYG-6, was prepared from an original concentrated tincture
menstruum containing sulfur and glvcerin ir. 99+% alcohol. The
oriqinal concentrated tincture was then diluted to 30X potency
(10 30 times the original concentration) with sterile isotonic
saline. Ferrous gluconat.e, a magnetically permeable substance
in a homeopathic potency of 4 x (10 4), was added to the
dilute homeopathic solution in order for it to hold a magnetic
charge when passed through a magnetic field. Injectable
dosage portions of O.~cc volumes were set asid~ as needed.
The formulations injected were controllahly magnetized during
administ~ation through the acupuncture sites as described
above.
Example 11
~ - 26 -
1 3 3 4 9 3 6 540270-2~,70
An injectable dosage form of an herb-hased
homeopathic medicament, designated INF-16, for the treatment
of bacterial infections, particularly staff and strep, was
prepared from an original concentrated tincture menstruum
containing extracts of the herbs Senecia scandens, Scutellaria
baicalensis, Magnolia officinalis, Lonicera japonica, and
Andrographis paniculata in 99+~ alcohol. The original
concentrated tincture was then diluted to 30X potencv (10 30
times the oriqinal concentration) with sterile isotonic
saline. Ferrous gluconate, a ma~qneticallv permeable subs~.ance
in a homeopathic potency of 4 x (7 0 ), was added to the
dilute homeopathic solution in order for it to hold a macnetic
charge when passed throuqh a magnetic field. In~ectable
dosage portions of 0.2cc volumes were set aside as needed.
The formulations injected were controllahlv magnetized durino
administration throuqh the acupuncture sites as described
above.
Example 12
An iniectable dosage form of an herb-based
homeopathic medicament, designated FLU-17, for the treatment
o' viral infections due to colds and influenza, particularly
rhino-~irus, was prepared from an original concentrated
tincture mens~ruum containing extracts of the herbs Lonicera
confusa, Chrysanthemum indi.cum, Vitex negundo, Eucdia lepta,
Ilex asprella, Menthol, and
- 27 _
. . . ....
1 3 3 4 9 3 6 PATENT
`
Baphicacanthus cusia in 99+~ alcohol. The original
concentrated tincture was then diluted to 30X potency (10 30
times the original concentration) with sterile isotonic
saline. Ferrous gluconate, a magneticallv permeable substance
in a homeopathic potencv of 4 x ~10 ), was added to the
dilute homeopathic solution in order for it to hold a magnetic
charge when passed through a magnetic field. In~ectable
dosaqe portions of 0.2cc volumes were set aside as needed.
The for~l~lations iniec~ed were controllablv magnetized during
administration through the acupuncture sites as described
above.
Example 13
An injectable dosage form of an herb-based
homeopathic medicament, designated AlI,-5, for the treatment of
hayfever and airborne alleraies, was prepared from ar original
concentrated ~incture menstruum containin~ extracts of the
herbs Centiana luta, Citrus aurantium, Tanacetum vulgare,
Chicus henedictus, Menyanthes trifoliata, Grindelia robusta,
and Ephedra sinica in 99~ alcohol. The orioinal concentrated
tincture was then diluted to 30X potency (10 30 ti~es the
original concentration) ~ith sterile isotoniC saline. Ferro~ls
gluconate, a magneticallv permeable substance in a homeopathic
potencv of 4 x (10 4), was ad~ed to the dilute homeopathic
solution in crder for it to hold a magnetic charge when passed
- 28 -
1 334936 PATÆNT
540270- 070
through a maqnetic field. Injectable dosage portions of 0.2cc
volumes were set aside as needed. The formulations injected
were controllably magnetized at the time of administratior.
through the acupuncture sites as described above.
Example 14
An injectable dosage form of an herb-based
homeopathic medicament, de.signated OP~-26, for the treatment
of chronic muscular and joint pain, having a homeopathic
potency of 5~ was prepared from an original concentrated
tincture menstruum containing an extract of the herb Rhus
toxicodendron in 99+~ alcohol. The original concentrated
tincture was then diluted to 30X potency (10 30 times the
original concentration) with sterile isotonic saline. Ferrous
gluconate, a magnetically permeable substance in a homeopathic
potency of 4 x (10 4), was added to the dilute homeopathic
solution in order for it to hold a magnetic charge when passed
through a magnetic field. Injectable dosage portions of 0.2cc
volumes were set aside as needed. The formulations injected
were controllablv magnetized during administration through the
acupuncture sites as described above.
Example 15
An injectable dosage form of a homeopathic
medicament, desiqnated SMK-30, for the tr~atment of nicotine
addiction and the craving to smoke cigarettes, other nicotine
containing tobacco products, and the like, having a
- 29 -
1 3 3 4 9 3 6 540270-2070
-
homeopathic potency of 30X was prepared from an original
concentrated tincture menstruum containing an extract of
cigarette smoke in 99+% alcohol. The original concentrated
tincture was then diluted to 30X potency (10 30 times the
original concentration~ with sterile isotonic saline. Ferrous
gluconate, a magneticallv permeable substance in a homeopathic
potency of 4 x (10 4), was added to the dilute homeopathic
solution in order for it to hold a magnetic charge when passed
through a magnetic field. Injectable dosage portions of 0.2cc
volumes were set aside as neede~. The formulations injected
were controllably magne~ized during administration through the
acupuncture sites as described above.
B. ORAL FORM
Example 16
An oral dosage form of the herb-based homeopathic
medicament FNG-ll, prepared as set forth in Example 1 above,
having a homeopathic potencv of 30X was prepared in accordance
with the procedure described above in connection with the p~ll
illustrated in Figure lB.
Example 17
An oral dosage form of the herb-based homeopathic
medicament HG-9, as in Example 2, having a homeopathic potency
of 30X, was prepared according to the method of Example 16.
Example 18
- 30 -
PATENT
1 3 3 4 9 3 6 540270-~070
`
An oral dosage form of the herb-based homeopathic
medicament VR-27, as in Example 3, having a homeopathic
potency of 30X, was prepared according to the method of
Example 16.
Example la
An oral dosage form of the herb-based homeopathic
medicament SPN-7, as in Example 4, having a homeopathic
potency of 30X, was prepared according to the method of
Example 16.
Example 20
An oral dosage form of the homeopathic medicament
TYR-10, as in Example 5, having a homeopathic potency of 30X,
was prepared according to the method of Example 16.
Example 21
An oral dosage form of the herb-based homeopathic
medicamert HRM-4, as in Example 6, having a homeopathic
potency of 30X, was prepared according to the method of
Example 16.
Example 22
An oral dosaqe form of the homeopathic medicament
TYR-12, as in Example 7, having a homeopathic potency of 30X,
was prepared according to the method of Example 16.
Example 23
An oral dosage form of the herb-based homeopathic
medicament RLX-22, as in Example 8, having a homeopathic
- 31 -
1 3 3 4 9 3 6 540270-2070
potency of 30X, was prepared according to the method of
Example 16.
Example 24
An oral dosage form of the herb-based homeopathic
medicament IMM-2, as in Example 9, having a homeopathic
potency of 30X, was prepared according to the method of
Example 16.
Example 25
An oral dosage form of the herb-based homeopathic
medicament HYG-6, as in Example 10, having a homeopathic
potencv of 30X, was prepared according to the method of
Example 16.
Example 26
An oral dosage form of the herb-based homeopathic
medicament INF-16, as in Example 11, having a homeopathic
potency of 30X, was prepared according to the method of
Example 16.
Example 27
An oral dosage form of the herb-based homeopathic
medicament GLG-17, as in Example 12, having a homeopathic
potency of 30X, was prepared according to the method of
Example 16.
Example 28
An oral dosage form of the herb-based homeopathic
medicament ALL-5, as in Example 13, having a homeopathic
- 32 -
PATENT
1 3 3 4 9 3 6 540270-~Q70
potency of 30X, was prepared according to the method of
Example 16.
Example 29
An oral dosage form of the herh-based homeopathic
medicament OPN-26, as in Example 14, having a homeopathic
potency of 30X, was prepared according to the method of
Example 16.
~xample 30
An oral dosage form of an herb-basea homeopathic
medicament, designated GU-14, for t.he treatment of gastric
discomfor~, borborvgmi, and flatus, having a homeopathic
potency of 30X, was prepared according to the method of
Example 16, where the original concentrated tincture menstruum
contained extracts of the herb Coryandrus sativa.
Clinical Examples
Example 31
A combined treatment regimen utilizing both the
injectable and oral dosage forms of the FNG-11 homeopathic
medicament Iprepared according to Examples 1 and 16,
respectivel~), was used in the treatment of a 44 year old
female patient. Prior to treatment the patient exhibited
symptoms including mood swings, premenstrual syndrome
(P.M.S.), and fatigue, and was diagnosed as a result of
- 33 -
1 3 3 4 9 PATENT
5~70-2070
visible yeast in a live cell analysis as suffering from
candidiasis. The injectable form dosaae of FN~-11 was
adminis~qred two times per week durins the first week and once
per week thereafter bilaterally to the two SP-6 acupuncture
points. Duration of treatment hy the injecta~le mode was fGr
a total period of four weeks. Oral dosage forms were
administered at an initial dosage rate of 3 tablets taken 5
times per day during the first week of treatment, reduced to 3
times per day during the second week of treatment and finally
to 2 times per day for the balance of the duration of the
treatment. The total duration of treatment under the oral
form was for a period of 4 weeks. As a result of the above
treatments, the patient's blood level yeast decreased by 60%.
The patien~'s P.M.S. and other symptoms were controlled.
Example 32
A combined treatment re~imen utilizing both the
injectable and oral dosage forms of the vR-27 homeopa~hic
medicament ~prepared according to Examples 3 and 18,
respectivelv), was used in the trea'ment of a 41 year old male
exhibiting symptoms including a history of prostatitis and
gonorrhea with active leisons approximately 60-70~ of the
PATEMT
1 3 3 4 9 3 6 540270-207~
time. The patient was diagnosed as being infected with herpes
simplex 2. The injectable form dosage of the VR-27 was
administered two times per week during the first week and once
per week thereafter bilaterally to the two ~-5 acupuncture
points and the oral form dosage was administered initially at
a rate of 3 tablets taken 5 times per dav durino the first
week of treatment, reduced to 3 times per dav during the
second week of treatment and finallv to 2 times per day for
the balance of the duration of the treatment. Bo.h the
injectable and oral form dosages were administered for a tota~
treatment ~eriod of 6 weeks. After 3 weeks of treatment, the
patient's condition improved to the extent that there were no
active lesions and no further outbreaks of genital herpes.
Example 33
A combined treatment regimen of oral and injectable
forms of VR-27 was utilized in the treatment of a 33 year old
female of slender build and good muscle structure. The
patient exhibited classic symptoms of Chronic Epstein-Barr
Virus including chronic fatigue, unrefreshed sleep, dark
circles under the eyes, headaches, burning eyes,
hypersensitivitv to bright lights and smoke, non-specific
muscle aches in shifting locales, lack of coordination, lack
of balan~e, and persistent bouts of depressions that sometimes
reached profound levels. She was uncertain of exact dates but
- 35 -
PATENT
1 3 3 4 9 3 6 540270-2070
felt that she had had most of these symptoms for several
years.
A blood test verified the diagnosis of Epstein-Barr
Virus. The E-B Virus antibo~y virus'titer (VCA) was positive
at 1:51~0.
The patient was treated on a weekly basis with the
homeopathic medicament by taking 3 oral tables t.i.d. The
injectable form of VR-~7 was injected through the TW-5 acu-
puncture point. Treatment continued for a period of approxi-
mately 2 months. At the end of this time the follow-up blood
work showed that the same anti-body titer had fallen to a
level of 1:320: well below the critical point and within the
ranqe considered normal. The clinical signs and symptoms
confirmed the lab work and the patient reported virtual
freedom from the previous physical and emotional problems.
She continued to be free of svmptoms 18 months later.
~xample 34
~ female patient 36 years old, who was slightlv
overweight ~xhihited symptoms of constant vaginal infections
with associated burninq, itching and discharge. She com-
plained of extremely low energy level and felt that she was in
a state of unremittin~ depression. Frequent attacks of acute
diarrhea after food intake were accompanied by headaches and
nausea. She feels much of her weight problem is water re-
tention (abdominal bloating~ and reports a large number of
- 36 -
PATFNT
1 3 3 4 9 3 6 540270-2070
-
various food allergies. Relatively the same roster of com-
plaints have been present in various combination for a period
that, she estimates, could be as long as twelve years. The
patient diagnosed as suffering from chronic candida albicans.
Initial laboratory tests disclosed the following levels:
IaG - 136 (normal max 100)
JgA - ~14 (normal max loo!
IqM - 143 tnormal max 100)
The patient was treated with F~G-11 in injectable form in-
troduced into acupuncture point ~P-6 on a once a week basi~ in
addition to oral tablets of the same me~ication for 8 weeks.
Following treatment laboratory tests disclosed the following
levels:
IgG - Sl
IgA - 96
I~M - 99
The patient also reported a total cessation of the initiating
and chronic sv~ptoms complained of and has been fully comfort-
able with no recurrence since.
- 37 -
